5200 ILLUMINA WAY, SAN DIEGO, CA
Daniel M. Skovronsky, MD, PhD, appointed to the Board of Directors
Illumina, Inc. Annual Meeting Results; Board Elections and Auditor Ratification
Annual Report to Security Holders
Financial Results, Press Release
Completes Acquisition of SomaLogic
Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Appoints Dr. Eric Green as Chief Medical Officer
Illumina Completes $500 Million Public Offering of 4.750% Notes Due 2030
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Free Writing Prospectus
Definitive Revised Proxy Statement